PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login Register FREE

CEOP-MB protocol

Subscribe to Selected New Research on CEOP-MB protocol

0 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: chemotherapy protocol consisting of above cpds; used for treatment of non-Hodgkin's lymphoma

Bio-Agent Context: Research Results

-

Therapeutics: 5192

-

Drug Therapy: 116577

-

Combination Drug Therapy: 8322

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

CEOP-MB protocol

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

CEOP-MB protocol

-

Clinical Protocols

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

CEOP-MB protocol

-

Carbohydrates: 2945

-

Glycoconjugates: 631

-

Glycopeptides: 480

-

Bleomycin: 5151

*

CEOP-MB protocol

-

Glycosides: 338

-

Aminoglycosides: 1075

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15005

-

Epirubicin: 2010

*

CEOP-MB protocol

-

Amino Acids, Peptides, and Proteins

-

Peptides: 16074

-

Glycopeptides: 480

-

Bleomycin: 5151

*

CEOP-MB protocol

-

Enzymes and Coenzymes: 1

-

-

Tetrahydrofolates: 7

-

Formyltetrahydrofolates

-

Leucovorin: 3347

*

CEOP-MB protocol

-

Polycyclic Compounds: 58

-

Steroids: 13690

-

-

-

Pregnadienediols

-

Prednisone: 7158

*

CEOP-MB protocol

-

Aromatic Polycyclic Hydrocarbons: 581

-

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15005

-

Epirubicin: 2010

*

CEOP-MB protocol